HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chekanov, V. Articles by Karakozov, P. Search for Related Content PubMed PubMed Citation Articles by Chekanov, V. Articles by Karakozov, P. Related Collections Congestive Heart Failure Mechanical Circulatory Assistance

Adaptive Cardiac Binding: A New Method for Treatment of Dilated Cardiomyopathy

Heart Care Associates, Milwaukee Heart Institute at Aurora Sinai Medical Center, Milwaukee, Wisconsin, USA
¹ Institute for Biomedical Research, Clinic of Cardiac Surgery, Kaunas University of Medicine, Kaunas, Lithuania
² Vakhidov Scientific Center of Surgery, Tashkent, Uzbekistan

For reprint information contact: Valeri Chekanov, MD Tel: 1 414 219 7899 Fax: 1 414 219 6252 Email: vchekanov{at}yahoo.com, 945 N. 12th Street, Rm. W301, PO Box 342, Milwaukee, WI 53201-0342, USA.

Adaptive cardiac binding, a new surgical procedure for advanced heart failure, allows a gradual increase in compression on the dilated heart, with separate loads on the left and right ventricles. A canine model of biventricular heart failure (anastomosis between the carotid artery and jugular vein and doxorubicin administration) was created. Twenty-four dogs were divided into 4 groups: control, adynamic cardiomyoplasty, plastic cardiac binding, and adaptive cardiac binding. In the adaptive cardiac binding group, fluid was added (35, 15, and 10 mL) to each side of the pouch at weeks 1, 2, and 3. Left ventricular ejection fraction was 59% ± 4% before induction of heart failure and 27% ± 2% 6 weeks later. Immediately after the main operation, left ventricular ejection fractions were 35 ± 3% (cardiomyoplasty), 34% ± 4% (plastic cardiac binding), and 35% ± 4% (adaptive cardiac binding). Four weeks later, left ventricular ejection fraction had not changed in the cardiomyoplasty (37% ± 3%) and plastic cardiac binding (32% ± 2%) groups, but significantly increased in the adaptive cardiac binding group (48% ± 5%); it had decreased to 23% ± 4% in controls. Adaptive cardiac binding is a promising new surgical approach for patients with end-stage heart failure.